Coexistence of blaNDM–5 and tet(X4) in international high-risk Escherichia coli clone ST648 of human origin in China

Abstract

The emergence of pathogens is conferring resistance to last-resort therapies such as tigecycline, colistin, and carbapenems, limiting the therapeutic options, and raising concerns about the emergence of new “superbugs.” This study reports the first incident of a blaNDM–5 and tet(X4) co-harboring Escherichia coli with resistance to carbapenem and tigecycline recovered as the causative agent of a urinary tract infection in a 94-year-old patient. The E. coli strain ECCL209 carries multiple resistance genes [i.e., blaTEM–1B, blaNDM–5, blaCMY–2, aadA22, florR, erm(B), mph(A), erm(42), lnuG, qnrS1, and sul2] and exhibits resistance to almost all clinically used antibiotics. MLST analysis found that the strain belongs to ST648, considered a worldwide high-risk pandemic clone. Moreover, multiple plasmid incompatibility types were detected, i.e., IncHI1A, IncHI1B, IncFII, IncFIA, IncFIB, IncQ1, Col, and IncX4. Genetic analysis revealed that blaNDM–5 and tet(X4) genes were localized on two hybrid plasmids with multiple replicons. Continuous monitoring studies are suggested to quantify the antimicrobial resistance and assess the dissemination of such superbugs into a human healthcare setting.

Susceptibility and Virulence of Enterobacteriaceae Isolated from Urinary Tract Infections in Benin

“…Antibiotic resistance and the rapid spread of aminoglycosides and lactams such as cephalosporins and fluoroquinolones against uropathogenic bacteria compromise the clinical management of the infection and lead to a poor prognosis [ 42 ]. The multiple-drug resistance (MDR) of pathogenic bacteria may be associated with severe morbidity in urinary tract infections, leading to a major global health problem [ 43 , 44 , 45 ]. The non-regulation of the use of antibiotics in patients with access to over-the-counter prescriptions, the misuse of certain classes of antimicrobials, frequent self-medication with often random and inappropriate dosages, the premature discontinuation of treatment, the use of antibiotics as growth promoters in agriculture, the use of contraband molecules that are often less dosed or devoid of active ingredients, and unfavorable economic and social conditions are the main drivers that promote the emergence of bacteria that are multi-resistant to antibiotics [ 46 , 47 ].…”

Phenotypic heterogeneity unveils a negative correlation between antibiotic resistance and quorum sensing in Pseudomonas aeruginosa clinical isolates

“…Multidrug resistance (MDR) has been increased all over the world that is considered a public health threat (Magiorakos et al, 2012 ; Algammal et al, 2023a ). Several recent investigations reported the emergence of multidrug-resistant bacterial pathogens from different origins that increase the necessity for the proper use of antibiotics (Algammal et al, 2022 , 2023b ; Elbehiry et al, 2022 ; Shafiq et al, 2022 ). The common and essential use of antibiotics in managing chronic bacterial infections, often involving concurrent administration of multiple antibiotics, inevitably leads to the emergence and proliferation of MDR bacterial strains.…”

Meat and meat products as potential sources of emerging MDR Bacillus cereus: groEL gene sequencing, toxigenic and antimicrobial resistance

“…A previous molecular investigation emphasized that B. cereus harbored resistance genes against macrolides, tetracycline, and β-lactam antibiotics [ 6 ]. The indiscriminate use of antimicrobial agents consequences the development of multidrug-resistant pathogens [ 21 , 22 ].…”